Tomas G Olsson
1 – 10 of 51
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
- Predicting diagnosis and cognition with 18F-AV-1451 tau PET and structural MRI in Alzheimer's disease (
- 2017
- Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry (
- Increased basal ganglia binding of 18F-AV-1451 in patients with progressive supranuclear palsy (
- Modeling strategies for quantification of in vivo 18F-AV1451 binding in patients with tau pathology (
- 2015
- Role of CD8-positive cells in radioimmunotherapy utilizing (177)Lu-mAbs in an immunocompetent rat colon carcinoma model. (
- Evaluation of immune cell markers in tumor tissue treated with radioimmunotherapy in an immunocompetent rat colon carcinoma model. (
- 2014
- Change in Cell Death Markers During (177)Lu-mAb Radioimmunotherapy-Induced Rejection of Syngeneic Rat Colon Carcinoma. (
- (18)F-fluorocholine PET/CT compared with extended pelvic lymph node dissection in high-risk prostate cancer. (
- Sequential Radioimmunotherapy with (177)Lu- and (211)At-Labeled Monoclonal Antibody BR96 in a Syngeneic Rat Colon Carcinoma Model. (
- 2013
- A niobium water target for routine production of [(18)F]Fluoride with a MC 17 cyclotron. (